David Chambers

1.6k total citations · 1 hit paper
18 papers, 1.3k citations indexed

About

David Chambers is a scholar working on Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, David Chambers has authored 18 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 10 papers in Cardiology and Cardiovascular Medicine and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in David Chambers's work include Cardiac Ischemia and Reperfusion (11 papers), Cardiac Imaging and Diagnostics (8 papers) and Nitric Oxide and Endothelin Effects (3 papers). David Chambers is often cited by papers focused on Cardiac Ischemia and Reperfusion (11 papers), Cardiac Imaging and Diagnostics (8 papers) and Nitric Oxide and Endothelin Effects (3 papers). David Chambers collaborates with scholars based in United States, United Kingdom and France. David Chambers's co-authors include Loren F. Parmley, J. M Downey, G. C. Patterson, Joe M. McCord, D. H. Parks, Satoshi Yoshida, R ROY, James M. Downey, Derek M. Yellon and W D Kuehl and has published in prestigious journals such as Journal of Clinical Investigation, Circulation Research and The American Journal of Cardiology.

In The Last Decade

David Chambers

17 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Xanthine oxidase as a source of free radical damage in myocardial ischemia

1985 558 citations David Chambers, D. H. Parks et al. Journal of Molecular and Cellular Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Chambers United States	12	575	410	373	245	184	18	1.3k
Parinam S. Rao United States	18	372 0.6×	414 1.0×	223 0.6×	272 1.1×	104 0.6×	41	1.4k
G. C. Patterson United Kingdom	14	373 0.6×	421 1.0×	205 0.5×	187 0.8×	130 0.7×	25	1.2k
Joël de Leiris France	28	695 1.2×	559 1.4×	342 0.9×	625 2.6×	167 0.9×	99	2.3k
A Manning United Kingdom	23	991 1.7×	1.1k 2.6×	250 0.7×	622 2.5×	223 1.2×	62	2.2k
Véronique Maupoil France	24	248 0.4×	436 1.1×	307 0.8×	427 1.7×	83 0.5×	65	1.6k
M. Chopra United Kingdom	19	272 0.5×	680 1.7×	284 0.8×	450 1.8×	97 0.5×	31	1.8k
D. Feuvray France	25	622 1.1×	1.1k 2.7×	242 0.6×	776 3.2×	198 1.1×	61	1.8k
Pietro Paolo Elia Italy	6	326 0.6×	126 0.3×	170 0.5×	334 1.4×	59 0.3×	8	1.1k
David M. Ansley Canada	23	649 1.1×	390 1.0×	226 0.6×	387 1.6×	38 0.2×	42	1.6k
Shiro Hoshida Japan	26	1.4k 2.4×	965 2.4×	499 1.3×	621 2.5×	175 1.0×	106	2.7k

Countries citing papers authored by David Chambers

Since Specialization

Citations

This map shows the geographic impact of David Chambers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Chambers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Chambers more than expected).

Fields of papers citing papers by David Chambers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Chambers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Chambers. The network helps show where David Chambers may publish in the future.

Co-authorship network of co-authors of David Chambers

This figure shows the co-authorship network connecting the top 25 collaborators of David Chambers. A scholar is included among the top collaborators of David Chambers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Chambers. David Chambers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Morrow, Jason D., et al.. (2006). Quantification of 31 volatile organic compounds in whole blood using solid-phase microextraction and gas chromatography–mass spectrometry☆. Journal of Chromatography B. 832(2). 292–301. 119 indexed citations

Shattock, Michael J., Max Baghai, Wael I. Awad, et al.. (2004). K-ATP channels and preconditioning in the neonatal heart: are they up to the job. Journal of Molecular and Cellular Cardiology. 37(1). 365–366. 1 indexed citations

Ferrera, René, et al.. (2000). Microperfusion techniques for long-term hypothermic preservation. The Journal of Heart and Lung Transplantation. 19(8). 792–800. 15 indexed citations

Chu, Alan, David Chambers, W D Kuehl, et al.. (1991). Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs.. Journal of Clinical Investigation. 87(6). 1964–1968. 167 indexed citations

Chu, Alan, et al.. (1990). Ischemia-induced epicardial vasoconstriction. A potential mechanism for distant myocardial ischemia.. Circulation Research. 66(6). 1484–1490. 5 indexed citations

Chu, Alan, David Chambers, Chih‐Chung Lin, W D Kuehl, & Frederick R. Cobb. (1990). Nitric oxide modulates epicardial coronary basal vasomotor tone in awake dogs. American Journal of Physiology-Heart and Circulatory Physiology. 258(4). H1250–H1254. 75 indexed citations

Takahashi, Akihiko, et al.. (1989). Cardioplegia: relation of myocardial protection to infusion volume and duration. European Journal of Cardio-Thoracic Surgery. 3(2). 130–134. 4 indexed citations

Chambers, David. (1988). Myocardial protection with the St. Thomas' Hospital Cardioplegic solution is not enhanced by transient calcium reduction during early reperfusion. Journal of Molecular and Cellular Cardiology. 20. S45–S45.

Downey, James M., Tetsuji Miura, Lynne J. Eddy, et al.. (1987). Xanthine oxidase is not a source of free radicals in the ischemic rabbit heart. Journal of Molecular and Cellular Cardiology. 19(11). 1053–1060. 105 indexed citations

10.

Chambers, David, M.V. Braimbridge, & D HEARSE. (1987). Free radicals and cardioplegia Free radical scavengers improve postischemic function of rat myocardium. European Journal of Cardio-Thoracic Surgery. 1(1). 37–45. 23 indexed citations

11.

Yoshida, Shigeo, David Chambers, Lynne J. Eddy, et al.. (1985). Infarct size limitation by the xanthine oxidase inhibitor, allopurinol, in closed-chest dogs with small infarcts. Cardiovascular Research. 19(11). 686–692. 87 indexed citations

12.

Chambers, David, D. H. Parks, G. C. Patterson, et al.. (1985). Xanthine oxidase as a source of free radical damage in myocardial ischemia. Journal of Molecular and Cellular Cardiology. 17(2). 145–152. 558 indexed citations breakdown →

13.

Yoshida, Satoru, et al.. (1985). Nifedipine limits infarct size for 24 hours in closed chest coronary embolized dogs. Basic Research in Cardiology. 80(1). 76–87. 11 indexed citations

14.

Chambers, David, et al.. (1984). The role of vascular capacitance in the coronary arteries.. Circulation Research. 55(6). 751–762. 33 indexed citations

15.

Chambers, David, Derek M. Yellon, David J. Hearse, & James M. Downey. (1983). Effects of flurbiprofen in altering the size of myocardial infarcts in dogs: Reduction or delay?. The American Journal of Cardiology. 51(5). 884–890. 31 indexed citations

16.

Yellon, Derek M., et al.. (1983). Sustained limitation of myocardial necrosis 24 hours after coronary artery occlusion: Verapamil infusion in dogs with small myocardial infarcts. The American Journal of Cardiology. 51(8). 1409–1413. 43 indexed citations

17.

Downey, James M., David Chambers, & R D Wilkerson. (1982). The inability of isoproterenol or propranolol to alter the lateral dimensions of experimentally induced myocardial infarcts. Basic Research in Cardiology. 77(5). 486–498. 6 indexed citations

18.

Eddy, Lynne J., et al.. (1981). Lack of a direct metabolic effect of fructose, 1,6-diphosphate in ischemic myocardium. American Journal of Physiology-Heart and Circulatory Physiology. 241(4). H576–H582. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact